Undervalued Stocks Based On Cash Flows
Results
6
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ROVI New | €59.25 | 2.0% | 9.3% | €3.0b | €74.36 | 16.4 | 12.2% | 1.6% | Pharmaceuticals & Biotech | ||
BYTE | €5.00 | -2.0% | -18.0% | €149.8m | n/a | 692.1 | 60.9% | n/a | Consumer Services | ||
PANG | €1.55 | 0% | -9.9% | €55.7m | n/a | 3.3 | 96.1% | n/a | Pharmaceuticals & Biotech | ||
TUB | €3.05 | -3.0% | -16.9% | €369.9m | €4.14 | 0.5 | 82.9% | 6.7% | Materials | ||
ART | €29.50 | -2.6% | 161.1% | €1.6b | €34.25 | 30.3 | 21.0% | 0.6% | Capital Goods | ||
ACX | €17.44 | 6.0% | 72.2% | €4.3b | €17.84 | 80.4 | 33.9% | 3.6% | Materials |
Page 1 of 1